Andrew Stockdale

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

David P. Dearnaley, Isabel Syndikus, Helen Mossop et al. · The Lancet Oncology · 2016 · 1.3K citations · Full text

Medicine, Oncology, Radiation Oncology +17

Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2–Positive Metastatic Bladder Cancer

Thomas Powles, Robert Huddart, Tony Elliott et al. · Journal of Clinical Oncology · 2017 · 202 citations · Full text

Medicine, Oncology, Pharmacology +16

A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer

Thomas Powles, Matthew Wheater, Omar Din et al. · European Urology · 2015 · 100 citations

Medicine, Nephrology, Oncology +14

Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer

Thomas Powles, Naveed Sarwar, Andrew Stockdale et al. · JAMA Oncology · 2016 · 79 citations

Medicine, Oncology, Surgery +13

Radiotherapy: An effective treatment for extramammary Paget's disease

James D. Brierley, Andrew Stockdale · Clinical Oncology · 1991 · 64 citations

Medicine, Oncology, Radiation Oncology +7